Single center experience shows high technical success in endovascular repair of aortic pathology, suggesting further exploration is needed.
CMD LSA branch endografts represent a valid solution for complex Zone 2 aortic pathology, offering full endovascular repair with individualized anatomical adaptation over off-the-shelf solutions. Our outcomes demonstrate early feasibility with high technical success; however, further studies with larger cohorts and long-term follow-ups are warranted.
No takes yet. Share an insight, caveat, or question.
Cambiaghi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: